A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors

This early-phase study tests the safety, how the body processes (pharmacokinetics), and early signs of anti-cancer activity of a new experimental drug called HC010 in people with advanced solid tumors that have not responded to standard treatments. **You may be eligible if...** - You are between 18 and 75 years old - You have an advanced solid tumor confirmed by biopsy, and standard treatments have either failed or are not available - Your cancer has at least one measurable lesion on imaging - Your general health status is good (ECOG 0 or 1) - Your organ function (blood counts, liver, kidneys) is within acceptable ranges - Your expected survival is at least 3 months **You may NOT be eligible if...** - You are under 18 or over 75 - Your cancer does not have measurable disease - You have not failed at least one line of standard therapy - You have serious organ dysfunction or poor general health Talk to your doctor to see if this trial is right for you.